Clinical Trial Update: Efficacy and Safety Study of Trastuzumab and Paclitaxel Based Regimens to Treat HER2-positive Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating efficacy and safety of trastuzumab- and paclitaxel-based regimens for HER2-positive breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• HERCEPTIN (trastuzumab)
• Taxol (paclitaxel)

Snippet

Sponsor: Zhimin Shao | Conditions: HER-2 Positive Breast Cancer | Phase 2 | Status: UNKNOWN